Dr. Nicolas Mourier is Senior Vice President, Chemistry, Manufacturing and Control (CMC) at Altavant Sciences, Inc. He brings over 25 years of experience in the biopharmaceutical industry, including CMC for preclinical through commercial development programs and spanning multiple indications.
Dr. Mourier joined Altavant from Anchiano Therapeutics, where he most recently served as Vice President of Manufacturing. Dr. Mourier has also held key leadership positions as Senior Vice President, Manufacturing at Sanifit, Vice President, CMC at Inotek Pharmaceuticals (now Rocket Pharmaceuticals) and Senior Vice President of CMC at Celsus Therapeutics, PLC (now Akari Therapeutics, PLC), where he oversaw the Manufacturing and Pharmaceutical Development for all the pre-clinical and clinical assets. He also consulted for several small and large biotechnology companies as subject matter expert where he contributed to the development and approval of several drugs: obizur (Baxalta), iclusig (Ariad), firazyr (Shire), velcade and mepact (Takeda).
Dr. Mourier received his Ph.D. degree in organic chemistry from the University of Luminy in Marseille, France.